Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
2009 5
2010 3
2011 5
2012 3
2013 3
2014 1
2015 2
2016 1
2018 1
2022 2
2023 4
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
How to assess pharmacogenomic tests for implementation in the NHS in England.
Sanghvi S, Ferner RE, Scourfield A, Urquhart R, Amin S, Hingorani AD, Sofat R. Sanghvi S, et al. Among authors: scourfield a. Br J Clin Pharmacol. 2023 Sep;89(9):2649-2657. doi: 10.1111/bcp.15820. Epub 2023 Jul 20. Br J Clin Pharmacol. 2023. PMID: 37313748 Free article. Review.
The pitfalls of oximetry.
Lee J, Scourfield A, Crummy F. Lee J, et al. Among authors: scourfield a. Br J Hosp Med (Lond). 2015 May;76(5):306-7. doi: 10.12968/hmed.2015.76.5.306. Br J Hosp Med (Lond). 2015. PMID: 25959946 No abstract available.
Drug combinations for HIV: what's new?
Scourfield A, Waters L, Nelson M. Scourfield A, et al. Expert Rev Anti Infect Ther. 2011 Nov;9(11):1001-11. doi: 10.1586/eri.11.125. Expert Rev Anti Infect Ther. 2011. PMID: 22029520 Review.
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ. Magavern EF, et al. Among authors: scourfield a. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):100-103. doi: 10.1093/ehjcvp/pvab063. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34463331
The impact of the COVID-19 pandemic on cardiovascular disease prevention and management.
Dale CE, Takhar R, Carragher R, Katsoulis M, Torabi F, Duffield S, Kent S, Mueller T, Kurdi A, Le Anh TN, McTaggart S, Abbasizanjani H, Hollings S, Scourfield A, Lyons RA, Griffiths R, Lyons J, Davies G, Harris D, Handy A, Mizani MA, Tomlinson C, Thygesen JH, Ashworth M, Denaxas S, Banerjee A, Sterne JAC, Brown P, Bullard I, Priedon R, Mamas MA, Slee A, Lorgelly P, Pirmohamed M, Khunti K, Morris AD, Sudlow C, Akbari A, Bennie M, Sattar N, Sofat R; CVD-COVID-UK Consortium. Dale CE, et al. Among authors: scourfield a. Nat Med. 2023 Jan;29(1):219-225. doi: 10.1038/s41591-022-02158-7. Epub 2023 Jan 19. Nat Med. 2023. PMID: 36658423 Free article.
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ. Magavern EF, et al. Among authors: scourfield a. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):85-99. doi: 10.1093/ehjcvp/pvab018. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 33638977
29 results